The tools we use to measure lean mass in clinical trials (DXA) likely overestimate the muscle component of LBM loss because they cannot distinguish liver and muscle substrate changes from actual contractile protein loss
Treatment of alcohol use disorder from a psychological point of view
Experience the transformative effects of semaglutide and embark on a journey towards lasting weight management success
Heat shock proteins and ferroptosis
"Although the absolute risk of clinically recorded alopecia associated with GLP-1 receptor agonist use is low, the observed association may still influence patients' satisfaction, adherence, and decisions to start or continue therapy," Yong Chen, PhD, of the University of Pennsylvania's Perelman School of Medicine, wrote
Therefore, the early recognition and treatment of this condition not only has the potential to prevent the onset of T2D but also to reduce cardiovascular mortality